Sells general insurance products — motor, health, fire, marine and other lines — to retail and corporate policyholders across India. Earns from two distinct sources: insurance premiums (gross written premium of ₹47,174 crore in FY26, up 8% YoY) and investment income on the premium float (₹11,112 crore in FY26, up 38% YoY). Health & Personal Accident accounts for 47.5% of the premium book, with the balance spread across Motor (own damage and third party), Fire, Marine and other classes. Underwriting runs at a loss, with a combined ratio of 122.57% in FY26 (116.67% excluding a one-time wage revision impact of ₹3,525 crore), meaning claims and expenses exceed premium collected; the gap is bridged by investment income. Manages assets under management of ₹96,652 crore and holds a solvency ratio of 1.84x against the 1.5x regulatory minimum. Operates 411 offices across 28 states with 10,405 employees and holds a 12.74% share of the Indian general insurance industry. Recent initiatives include the Bharat Maritime Pool, a War Cover product for the Fire segment, and a Go Retail strategy to expand individual customer share. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Health & Personal Accident premium (48%), Motor premium (Own Damage and Third Party), Fire premium, Marine premium, Investment income on premium float. Claim-heavy general insurance with a significant investment float that underwrites the underwriting loss
| ₹ crore · consolidated | FY21 | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| EBITDA (ex other income) | — | — | — | — | — |
| margin % | — | — | — | — | — |
| Owners' profit | 1,628 | 178 | 1,061 | 972 | 1,354 |
| EPS, as reported (₹) | — | — | — | — | — |
| ROE % · ROCE % | — · — | — · — | — · — | — · — | — · — |
| Debt / equity (x) | — | — | — | — | — |
| Cash from operations | 777 | (4,052) | (5,855) | (3,390) | (4,532) |
| Capex | (99) | (117) | (98) | (116) | (80) |
| ₹ crore | Q1 FY24 | Q2 FY24 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Profit before tax | — | — | — | — | — | — | — | — |
| Net profit | 266 | (195) | 322 | 392 | 20 | 377 | 564 | (244) |
| EPS (₹) | — | — | — | — | — | — | — | — |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| THE NEW INDIA ASSU CO LTD ◆ | — | — | — | — | — | — | — | — |
| STAR HEALTH & AL INS CO L | — | — | — | — | — | — | — | — |
| GO DIGIT GENERAL INS LTD | — | — | — | — | — | — | — | — |
| ICICI LOMBARD GIC LIMITED | — | — | — | — | — | — | — | — |
| GENERAL INS CORP OF INDIA | — |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 11 Sept 2026 · S Sivasankar gets additional charge as CMD of New India Assurance | management changes | high | — | — |
| 9 Sept 2026 · New India Assurance appoints statutory auditors for FY 2026-27 | management changes | medium | — | — |
| 9 Sept 2026 · New India Assurance plans to sell 1.05 crore NSE shares in IPO | capital market events | medium | — | — |
| 1 Sept 2026 · New India Assurance responds to NSE query on sudden volume spike | general | low | — | — |
| 31 Aug 2026 · NSE seeks clarification from New India Assurance on unusual trading volume | regulatory legal | medium | — | — |
| 27 Aug 2026 · Income tax refund of Rs. 78.39 crore received for AY 2022-23 | regulatory legal | medium | — | — |
| 6 Aug 2026 · BSE Volume Movement Letter - Response | compliance | low | — | — |
| 6 Aug 2026 · BSE seeks clarification on volume movement, reply awaited | regulatory legal | medium | — | — |
| 31 Jul 2026 · CMD Girija Subramanian ceases on superannuation w.e.f. 31 July 2026 | management changes | critical | — | — |
| 29 Jul 2026 · NIACL submits BRSR for FY 2025-26 to BSE and NSE | compliance | medium | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
| NIVA BUPA HEALTH INS CO L | — | — | — | — | — | — | — | — |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| Profit growth | (162.2) | 21.9 | 12 of 12 | 0% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
